Development of new predictive markers for endocrine therapy and resistance in breast cancer

By Henriksen Katrine   Sonne-Hansen Katrine   Kirkegaard Tove   Frogne Thomas   Lykkesfeldt Anne  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 795-801

Informa Healthcare

Access to resources Recommend Favorite

Predictors of response to second-line endocrine therapy for breast cancer

By Cheung K.L.   Willsher P.C.   Pinder S.E.   Ellis I.O.   Elston C.W.   Nicholson R.I.   Blamey R.W.   Robertson a.J.F.R.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 219-224

Springer Publishing Company

Access to resources Recommend Favorite

Resistance to endocrine therapy in breast cancer

By Kurebayashi Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

By Köstler Wolfgang J.   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 73-84

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy of breast cancer: a surgical perspective

By Dixon J.M.   Anderson T.J.   Miller W.R.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2214-2221

Elsevier

Access to resources Recommend Favorite